A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron.

Bah, A; Wegmuller, R; Cerami, C; Kendall, L; Pasricha, SR; Moore, SE; Prentice, AM; (2016) A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron. BMC pregnancy and childbirth, 16 (1). p. 157. ISSN 1471-2393 DOI: https://doi.org/10.1186/s12884-016-0934-8

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/s12884-016-0934-8

Abstract

Share

Download

Filename: art%3A10.1186%2Fs12884-016-0934-8.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar